Genetic or pharmacological reduction of PERK enhances cortical- and hippocampus-dependent cognitive function
Abstract:
A method for improving a cognitive function in a subject comprising administering to said subject an active agent reducing PKR-like endoplasmic reticulum kinase (PERK) activity is provided.
Information query
Patent Agency Ranking
0/0